IL162189A0 - Pyrimidine compounds - Google Patents
Pyrimidine compoundsInfo
- Publication number
- IL162189A0 IL162189A0 IL16218902A IL16218902A IL162189A0 IL 162189 A0 IL162189 A0 IL 162189A0 IL 16218902 A IL16218902 A IL 16218902A IL 16218902 A IL16218902 A IL 16218902A IL 162189 A0 IL162189 A0 IL 162189A0
- Authority
- IL
- Israel
- Prior art keywords
- pyrimidine compounds
- pyrimidine
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/000,742 US6693097B2 (en) | 2001-11-30 | 2001-11-30 | Pyrimidine compounds |
| US10/192,347 US6660733B2 (en) | 2001-11-30 | 2002-07-10 | 2,4,6-trisubstituted-pyrimidine compounds |
| PCT/US2002/038161 WO2003047516A2 (en) | 2001-11-30 | 2002-11-27 | Pyrimidine compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL162189A0 true IL162189A0 (en) | 2005-11-20 |
Family
ID=26668093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16218902A IL162189A0 (en) | 2001-11-30 | 2002-11-27 | Pyrimidine compounds |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US6958332B2 (de) |
| EP (1) | EP1458687B1 (de) |
| JP (1) | JP2005519034A (de) |
| KR (1) | KR100950122B1 (de) |
| CN (1) | CN100349876C (de) |
| AU (1) | AU2002357033B2 (de) |
| BR (1) | BR0214809A (de) |
| CA (1) | CA2468349A1 (de) |
| IL (1) | IL162189A0 (de) |
| IS (1) | IS7287A (de) |
| MX (1) | MXPA04005181A (de) |
| NO (1) | NO328144B1 (de) |
| NZ (1) | NZ533437A (de) |
| RU (1) | RU2320658C2 (de) |
| TW (1) | TWI256953B (de) |
| WO (1) | WO2003047516A2 (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6693097B2 (en) * | 2001-11-30 | 2004-02-17 | Synta Pharmaceuticals Corp. | Pyrimidine compounds |
| AU2002357033B2 (en) * | 2001-11-30 | 2009-05-07 | Synta Pharmaceuticals Corporation | Pyrimidine compounds |
| JP4768265B2 (ja) * | 2002-10-15 | 2011-09-07 | シンタ ファーマシューティカルズ コーポレーション | 新規化合物 |
| CA2545260A1 (en) * | 2003-11-10 | 2005-05-26 | Synta Pharmaceuticals, Corp. | Compositions and methods for modulating c-rel-dependent cytokine production |
| CA2545259A1 (en) * | 2003-11-10 | 2005-05-26 | Synta Pharmaceuticals, Corp. | Heteroaryl-hydrazone compounds |
| AU2004289304A1 (en) * | 2003-11-10 | 2005-05-26 | Synta Pharmaceuticals, Corp. | Pyridine compounds |
| AU2004289303A1 (en) * | 2003-11-10 | 2005-05-26 | Synta Pharmaceuticals, Corp. | Fused heterocyclic compounds |
| EP1737845A4 (de) * | 2004-04-13 | 2010-07-21 | Synta Pharmaceuticals Corp | Disalz-hemmer der il-12-produktion |
| JP4990766B2 (ja) * | 2004-07-01 | 2012-08-01 | シンタ ファーマシューティカルズ コーポレーション | 二置換型ヘテロアリール化合物 |
| CA2579143A1 (en) | 2004-09-13 | 2006-03-23 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| TW200628463A (en) * | 2004-11-10 | 2006-08-16 | Synta Pharmaceuticals Corp | Heteroaryl compounds |
| TW200630363A (en) * | 2004-11-10 | 2006-09-01 | Synta Pharmaceuticals Corp | Process for preparing trisubstituted pyrimidine compounds |
| JP2008519850A (ja) * | 2004-11-10 | 2008-06-12 | シンタ ファーマシューティカルズ コーポレーション | Ｉｌ−１２調節化合物 |
| EP1827447A1 (de) * | 2004-11-19 | 2007-09-05 | Synta Pharmaceuticals Corporation | Pyrimidin-verbindungen und ihre verwendungen |
| US20070032493A1 (en) * | 2005-05-26 | 2007-02-08 | Synta Pharmaceuticals Corp. | Method for treating B cell regulated autoimmune disorders |
| TW200804307A (en) * | 2005-10-27 | 2008-01-16 | Synta Pharmaceuticals Corp | Process for preparing mesylate salts of IL-12 inhibitory compounds |
| AU2006323944B2 (en) * | 2005-12-08 | 2012-08-16 | Merck Serono Sa | Antiproliferative pyrimidyl, fused pyrimidyl and pyrimidyl hydrazones |
| WO2008110891A2 (en) * | 2007-03-09 | 2008-09-18 | Orchid Research Laboratories Limited, | New heterocyclic compounds |
| WO2009100406A2 (en) * | 2008-02-07 | 2009-08-13 | Synta Pharmaceuticals Corp. | Topical formulations for the treatment of psoriasis |
| AU2009221089B2 (en) | 2008-03-07 | 2013-12-05 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40 |
| LT2262778T (lt) | 2008-03-07 | 2019-11-11 | Acraf | 1-benzil-3-hidroksimetilindazolo dariniai ir jų panaudojimas gydant ligas, pagrįstas mcp-1, cxcr1 ir p40 raiška |
| WO2010074284A1 (ja) | 2008-12-26 | 2010-07-01 | 味の素株式会社 | ピラゾロピリミジン化合物 |
| WO2011078221A1 (ja) * | 2009-12-24 | 2011-06-30 | 味の素株式会社 | イミダゾピリダジン化合物 |
| DK2595965T3 (en) | 2010-07-20 | 2016-08-22 | Vestaron Corp | Insecticidal triazines and pyrimidines |
| CN105963300B (zh) * | 2015-03-13 | 2019-06-11 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | PIKfyve抑制剂抗辐射损伤的用途 |
| CN106279041A (zh) * | 2016-08-16 | 2017-01-04 | 四川思睿博生物科技有限公司 | 苯基嘧啶衍生物及其制备方法和用途 |
| RU2020130837A (ru) | 2018-02-21 | 2022-03-21 | ЭйАй ТЕРАПЬЮТИКС, ИНК. | Комбинационная терапия апилимодом и глутаматергическими агентами |
| WO2023118896A1 (en) | 2021-12-23 | 2023-06-29 | Subintro Limited | Novel antiviral compositions comprising oleic acid |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6706264B1 (en) * | 1994-03-14 | 2004-03-16 | Genetics Institute, Llc | Use of IL-12 antagonists in the treatment of conditions promoted by an increase in levels of IFN-y |
| GB9905075D0 (en) * | 1999-03-06 | 1999-04-28 | Zeneca Ltd | Chemical compounds |
| WO2000062778A1 (en) * | 1999-04-15 | 2000-10-26 | Bristol-Myers Squibb Co. | Cyclic protein tyrosine kinase inhibitors |
| US6384032B1 (en) * | 1999-06-17 | 2002-05-07 | Shionogi Bioresearch Corp. | Inhibitors of IL-12 production |
| WO2001047921A1 (en) * | 1999-12-28 | 2001-07-05 | Pharmacopeia, Inc. | Pyrimidine and triazine kinase inhibitors |
| US6525051B2 (en) * | 2000-03-27 | 2003-02-25 | Schering Aktiengesellschaft | N-heterocyclic derivatives as NOS inhibitors |
| US6680315B2 (en) * | 2000-06-15 | 2004-01-20 | Synta Pharmaceuticals Corp. | Triazine compounds |
| US6693097B2 (en) * | 2001-11-30 | 2004-02-17 | Synta Pharmaceuticals Corp. | Pyrimidine compounds |
| AU2002357033B2 (en) * | 2001-11-30 | 2009-05-07 | Synta Pharmaceuticals Corporation | Pyrimidine compounds |
| CA2545259A1 (en) * | 2003-11-10 | 2005-05-26 | Synta Pharmaceuticals, Corp. | Heteroaryl-hydrazone compounds |
-
2002
- 2002-11-27 AU AU2002357033A patent/AU2002357033B2/en not_active Ceased
- 2002-11-27 CN CNB028239512A patent/CN100349876C/zh not_active Expired - Lifetime
- 2002-11-27 NZ NZ533437A patent/NZ533437A/en not_active IP Right Cessation
- 2002-11-27 IL IL16218902A patent/IL162189A0/xx unknown
- 2002-11-27 JP JP2003548777A patent/JP2005519034A/ja not_active Withdrawn
- 2002-11-27 BR BR0214809-9A patent/BR0214809A/pt not_active IP Right Cessation
- 2002-11-27 KR KR1020047008313A patent/KR100950122B1/ko not_active IP Right Cessation
- 2002-11-27 RU RU2004119853/04A patent/RU2320658C2/ru active IP Right Revival
- 2002-11-27 MX MXPA04005181A patent/MXPA04005181A/es active IP Right Grant
- 2002-11-27 EP EP02804468A patent/EP1458687B1/de not_active Expired - Lifetime
- 2002-11-27 WO PCT/US2002/038161 patent/WO2003047516A2/en active Application Filing
- 2002-11-27 CA CA002468349A patent/CA2468349A1/en not_active Abandoned
- 2002-11-29 TW TW091134807A patent/TWI256953B/zh not_active IP Right Cessation
-
2003
- 2003-09-05 US US10/655,672 patent/US6958332B2/en not_active Expired - Lifetime
-
2004
- 2004-05-26 IS IS7287A patent/IS7287A/is unknown
- 2004-06-29 NO NO20042742A patent/NO328144B1/no not_active IP Right Cessation
-
2005
- 2005-07-29 US US11/193,002 patent/US7470681B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003047516A3 (en) | 2003-07-31 |
| US20060030560A1 (en) | 2006-02-09 |
| RU2320658C2 (ru) | 2008-03-27 |
| MXPA04005181A (es) | 2005-06-17 |
| CN100349876C (zh) | 2007-11-21 |
| JP2005519034A (ja) | 2005-06-30 |
| EP1458687B1 (de) | 2012-01-11 |
| US20040053937A1 (en) | 2004-03-18 |
| KR20050058257A (ko) | 2005-06-16 |
| US7470681B2 (en) | 2008-12-30 |
| CA2468349A1 (en) | 2003-06-12 |
| NO328144B1 (no) | 2009-12-14 |
| NZ533437A (en) | 2007-05-31 |
| IS7287A (is) | 2004-05-26 |
| TW200400190A (en) | 2004-01-01 |
| EP1458687A4 (de) | 2005-03-23 |
| AU2002357033B2 (en) | 2009-05-07 |
| AU2002357033A1 (en) | 2003-06-17 |
| US6958332B2 (en) | 2005-10-25 |
| WO2003047516A2 (en) | 2003-06-12 |
| BR0214809A (pt) | 2004-09-14 |
| KR100950122B1 (ko) | 2010-03-30 |
| RU2004119853A (ru) | 2006-01-10 |
| NO20042742L (no) | 2004-08-24 |
| TWI256953B (en) | 2006-06-21 |
| EP1458687A2 (de) | 2004-09-22 |
| CN1599726A (zh) | 2005-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1070071A1 (en) | New pyrimidine compounds | |
| IL150934A0 (en) | Pyrimidine compounds | |
| IL162189A0 (en) | Pyrimidine compounds | |
| AU2002349297A8 (en) | Statin-like compounds | |
| GB0101996D0 (en) | Organtic compounds | |
| GB0112324D0 (en) | Compounds | |
| GB0102668D0 (en) | Compounds | |
| GB0108102D0 (en) | Compounds | |
| GB0102673D0 (en) | Compounds | |
| GB0102665D0 (en) | Compounds | |
| GB0112802D0 (en) | Pyrimidine derivatives | |
| GB0112803D0 (en) | Pyrimidine derivatives | |
| GB0129013D0 (en) | Compounds | |
| EP1458669A4 (de) | Neurologisch wirksame verbindungen | |
| GB0119477D0 (en) | Pyrimidine derivatives | |
| GB0219386D0 (en) | Compounds | |
| GB0108097D0 (en) | Compounds | |
| GB0105098D0 (en) | Compounds | |
| GB0119475D0 (en) | Pyrimidine derivatives | |
| GB0112808D0 (en) | Pyrimidine derivatives | |
| GB0112805D0 (en) | Pyrimidine derivatives | |
| GB0112807D0 (en) | Pyrimidine derivatives | |
| GB0112804D0 (en) | Pyrimidine derivatives | |
| GB0112809D0 (en) | Pyrimidine derivatives | |
| SI1567522T1 (sl) | Pirimidinske spojine |